Episodes

  • The Coffee Cholesterol Trap: Why Your Brewing Method Could Be Raising Your LDL (and How to Fix It for a Healthier Heart)

    The Coffee Cholesterol Trap: Why Your Brewing Method Could Be Raising Your LDL (and How to Fix It for a Healthier Heart)
    Apr 27 2026
    Discover the hidden cholesterol risk in your daily coffee—unfiltered brews like French press, espresso, and Turkish coffee pack diterpenes (cafestol and kahweol) that can spike LDL by 5-8 mg/dL, while paper-filtered drip keeps your heart protected. In this science-packed episode, we break down landmark studies on coffee brewing methods, heart health, longevity, and practical swaps that could slash cardiovascular risk—perfect for health-conscious listeners obsessed with wellness, nutrition, and longevity.
    Show More Show Less
    7 mins
  • Creatine Supplementation 2026: Evidence-Based Benefits for Muscle Performance, Cognitive Function, and Metabolic Health

    Creatine Supplementation 2026: Evidence-Based Benefits for Muscle Performance, Cognitive Function, and Metabolic Health
    Apr 24 2026
    Recent peer-reviewed studies demonstrate that optimized creatine protocols extend beyond athletic performance to deliver measurable improvements in brain health, including enhanced memory, executive function, and neuroprotection, positioning creatine as a key nootropic for cognitive longevity. In addition to supporting lean muscle mass and strength gains, emerging research highlights creatine’s role in improving metabolic efficiency, mitochondrial function, and energy regulation, offering applications for aging populations and metabolic health management. This science-backed update on creatine dosing strategies provides fitness professionals, healthcare practitioners, and informed consumers with practical, evidence-driven guidance to maximize physiological and neurological outcomes.
    Show More Show Less
    4 mins
  • Preserving Muscle Mass While Using GLP-1 Medications (Ozempic, Wegovy, Mounjaro)

    Preserving Muscle Mass While Using GLP-1 Medications (Ozempic, Wegovy, Mounjaro)
    Apr 22 2026
    In this episode, we address the growing clinical concern of lean-mass loss associated with GLP-1 receptor agonists such as semaglutide and tirzepatide, where studies show 20 to 45 percent of weight lost can come from muscle tissue. The discussion examines the mechanisms behind this risk and presents evidence-based strategies — including higher protein intake of 1.2 to 1.6 grams per kilogram of body weight and regular resistance training — to preserve muscle while achieving the metabolic benefits of these medications. Practical guidance is provided for patients and clinicians seeking to optimize body composition outcomes during treatment.
    Show More Show Less
    5 mins
  • NEAT extremes- The science of spontaneous energy expenditure

    NEAT extremes- The science of spontaneous energy expenditure
    Apr 19 2026
    3 mins
  • The 40-Gram Threshold: Timing, Tension, and Whey Efficacy

    The 40-Gram Threshold: Timing, Tension, and Whey Efficacy
    Apr 14 2026
    3 mins
  • Is sitting down equally harmful for everyone

    Is sitting down equally harmful for everyone
    Apr 8 2026
    2 mins
  • How can your heart rate variability predict if you’re gonna get the flu?

    How can your heart rate variability predict if you’re gonna get the flu?
    Apr 6 2026
    3 mins
  • New study shows that people over 50 who are sedentary can reverse their age by 20 years by exercising

    New study shows that people over 50 who are sedentary can reverse their age by 20 years by exercising
    Mar 22 2026
    2 mins